These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 11689632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors.
    Toma J, Whitcomb JM, Petropoulos CJ, Huang W.
    AIDS; 2010 Sep 10; 24(14):2181-6. PubMed ID: 20639728
    [Abstract] [Full Text] [Related]

  • 5. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE.
    J Virol; 2005 Jun 10; 79(11):6957-68. PubMed ID: 15890935
    [Abstract] [Full Text] [Related]

  • 6. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
    Chabot DJ, Zhang PF, Quinnan GV, Broder CC.
    J Virol; 1999 Aug 10; 73(8):6598-609. PubMed ID: 10400757
    [Abstract] [Full Text] [Related]

  • 7. Contrasting use of CCR5 structural determinants by R5 and R5X4 variants within a human immunodeficiency virus type 1 primary isolate quasispecies.
    Yi Y, Singh A, Shaheen F, Louden A, Lee C, Collman RG.
    J Virol; 2003 Nov 10; 77(22):12057-66. PubMed ID: 14581542
    [Abstract] [Full Text] [Related]

  • 8. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
    Gray L, Roche M, Churchill MJ, Sterjovski J, Ellett A, Poumbourios P, Sherieff S, Wang B, Saksena N, Purcell DF, Wesselingh S, Cunningham AL, Brew BJ, Gabuzda D, Gorry PR.
    J Virol; 2009 Jun 10; 83(11):5430-41. PubMed ID: 19321618
    [Abstract] [Full Text] [Related]

  • 9. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4.
    Esté JA, Cabrera C, Blanco J, Gutierrez A, Bridger G, Henson G, Clotet B, Schols D, De Clercq E.
    J Virol; 1999 Jul 10; 73(7):5577-85. PubMed ID: 10364306
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.
    Singh A, Collman RG.
    J Virol; 2000 Nov 10; 74(21):10229-35. PubMed ID: 11024154
    [Abstract] [Full Text] [Related]

  • 11. Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo.
    Reeves JD, Hibbitts S, Simmons G, McKnight A, Azevedo-Pereira JM, Moniz-Pereira J, Clapham PR.
    J Virol; 1999 Sep 10; 73(9):7795-804. PubMed ID: 10438870
    [Abstract] [Full Text] [Related]

  • 12. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
    Ghaffari G, Tuttle DL, Briggs D, Burkhardt BR, Bhatt D, Andiman WA, Sleasman JW, Goodenow MM.
    J Virol; 2005 Nov 10; 79(21):13250-61. PubMed ID: 16227248
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
    Dervillez X, Klaukien V, Dürr R, Koch J, Kreutz A, Haarmann T, Stoll M, Lee D, Carlomagno T, Schnierle B, Möbius K, Königs C, Griesinger C, Dietrich U.
    J Virol; 2010 Oct 10; 84(19):10131-8. PubMed ID: 20660187
    [Abstract] [Full Text] [Related]

  • 15. Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists.
    Princen K, Hatse S, Vermeire K, De Clercq E, Schols D.
    Retrovirology; 2004 Mar 08; 1():2. PubMed ID: 15169555
    [Abstract] [Full Text] [Related]

  • 16. Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains.
    Sironi F, Malnati M, Mongelli N, Cozzi P, Guzzo C, Ghezzi S, Martínez-Romero C, García-Sastre A, Lusso P, Jabes D, Biswas P.
    J Transl Med; 2015 Apr 02; 13():107. PubMed ID: 25888743
    [Abstract] [Full Text] [Related]

  • 17. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F, Borman AM, Brand D, Girard M.
    AIDS Res Hum Retroviruses; 1999 May 20; 15(8):731-43. PubMed ID: 10357469
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.
    Xiang SH, Pacheco B, Bowder D, Yuan W, Sodroski J.
    Virology; 2013 Mar 30; 438(1):5-13. PubMed ID: 23369572
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.